MDQK.HM MediNavi AG (HAM) rises 200% to €7.50 on 10 Feb 2026: volume-driven outlook

MDQK.HM stock opened at €2.50 and closed at €7.50 on 10 Feb 2026 after a 200.00% intraday gain on the HAM exchange in Germany. The move came on very low turnover — volume 35 versus an average of 41 — which points to thin liquidity rather than broad market buying. Traders should treat the spike as a high-volume mover trade setup, not proof of a fundamental turnaround.

Intraday move and trading facts for MDQK.HM stock

MediNavi AG (MDQK.HM) traded between a day low €2.50 and day high €7.50 on 10 Feb 2026 on HAM, with a reported change €5.00 (200.00%). Volume was 35 against an average volume of 41, and the stock opened at €2.50 after a previous close of €2.50. The percentage move is large because the stock trades thinly on the exchange, amplifying price swings.

No fresh company report or earnings to explain the MDQK.HM stock spike

There is no new earnings announcement or EPS data for MediNavi AG in public filings to justify the move; EPS and PE are listed as None. We checked the company site for updates and found no same-day release MediNavi website. With no confirmed news, low liquidity is the most plausible immediate driver of the intraday rise.

Fundamental snapshot and valuation signals for MDQK.HM stock

MediNavi sits in the Healthcare sector, Medical – Healthcare Information Services industry. Reported metrics show a price 50-day average €2.50 and 200-day average €2.00, placing the current €7.50 price well above both. Enterprise value to EBITDA is 2.17, and the current ratio is 41.50, which indicates strong short-term liquidity on the balance-sheet measures provided. Note that several standard valuation gauges are not available: PE and EPS are missing, market cap displays as 0 and shares outstanding are not reported.

Technical indicators and what they mean for MDQK.HM stock trading

Standard technical signals are limited by sparse trade history and data gaps: RSI is listed as 0.00 and MACD values are 0.00, which reflects insufficient continuous pricing data. The ATR is 5.00, showing large absolute intraday swings relative to recent prices. Price positioning above the 50-day €2.50 and 200-day €2.00 averages suggests short-term momentum, but low volume and erratic data make technical reads high risk.

Meyka AI grade and model forecast for MDQK.HM stock

Meyka AI rates MDQK.HM with a score out of 100: 62.62 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target €9.50, implying an upside of 26.67% vs the current €7.50. Forecasts are model-based projections and not guarantees.

Risks and short-term trading strategy on MDQK.HM stock

Main risks are thin liquidity, data gaps in public filings, and the lack of a clear corporate catalyst; small orders can move the price dramatically. For short-term traders, use tight size limits, limit orders, and clearly defined stop levels. For longer-term investors, wait for reliable company reports and consistent volume before adding exposure.

Final Thoughts

MDQK.HM stock posted a dramatic 200.00% intraday rise to €7.50 on 10 Feb 2026 on HAM, but the underlying picture is mixed. Thin volume (35) and missing EPS/PE data point to a liquidity-driven spike rather than validated fundamental improvement. Meyka AI rates MDQK.HM with 62.62 out of 100 (Grade B, HOLD) after weighing sector comparisons, key metrics and growth signals. Meyka AI’s forecast model projects a €9.50 12-month target, an implied upside of 26.67% from today’s price; this projection is model-based and not a guarantee. Traders should treat the move as an elevated-risk high-volume mover: consider small position sizes, limit orders, and confirmable company updates before increasing exposure. For real-time company details refer to the official site MediNavi website and our stock page at Meyka MDQK.HM.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.